Allogeneic-MSC

mesenchymal stem cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic-MSC, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy [Phase 2]